Rempex | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

359 results for “Rempex”

Trials

View all 329 →

Cardioinhibitory Reflex Syncope. Permanent Pacemaker Therapy or Cardioneuroablation?

90 participants · First posted May 11, 2023

Cardioneuroablation in Reflex Syncope (CARDIOSYRE Trial)

92 participants · First posted Aug 24, 2022

Active, not recruiting

The Effect of Earplugs on Gag Reflex and Patient Comfort in Root Canal Treatment

40 participants · First posted Mar 25, 2026

Drugs

View all 12 →

broad-spectrum carbapenemase inhibitors (Rempex)

Rumex acetosella whole

Rumex obtusifolius pollen

Organizations

Rempex Pharmaceuticals, Inc.

United States

Thomas More Kempen

Belgium

Remix Therapeutics, Inc.

United States

News

View all 10 →

Complicated Urinary Tract Infection Pipeline Shows Robust Development with 12+ Companies Advancing Novel Therapies

Ascendis Pharma Faces Revenue Shortfall, Pipeline Advances Temper Outlook

FDA Clears Medline's REFLEX HYBRID Nitinol Implants for Foot and Ankle Surgery

Page 1 of 36